Artificial Intelligence Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
Building an AI-Fluent Organization: How Pfizer is helping colleagues understand, embrace, and apply AI
Pfizer has been utilizing artificial intelligence (AI) across our business for some time, but recent advancements in technology combined with advancements in biology are converging to create a scientific renaissance set to transform health as we know it. That reality is already upon us.According to Pfizer CEO Albert Bourla, the biggest barrier to unlock this potential is fear of the unknown. "It is not a question of technology," Bourla said in a recent conversation with Nikolai Tangen of the...
April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More
April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire.In April, Pfizer colleagues were honored in the list of 2026 Healthcare Businesswomen’s Association (HBA) Luminaries and Rising Stars, we recognized vaccines’ impact during World Immunization Week, and Pfizer scientists highlighted our research efforts.CEO Albert Bourla recognized Pfizer scientists who were...
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos
In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads.The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care. Cancer research is moving faster than ever, but that progress is not always reflected in the patient experience. AI may be starting to change that. The last episode of Science Will Win Season 6 follows the human journey, from...
How AI Is Already Reshaping Cancer Care
When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on...
The 6th Season of 'Science Will Win' Takes on Cancer
On February 4th, Pfizer observed World Cancer Day, a global effort to raise awareness of cancer and to encourage its prevention, detection, and treatment. We are on a mission to outdo cancer and make 8 breakthroughs in the fight against the disease by 2030.It all starts with education, which is why we’re excited to announce that the new season of our award-winning flagship podcast, Science Will Win, which launched today, is tackling cancer head-on with the help of expert doctors and scientists.N...
January Social Media Round-Up—2026 Strategic Priorities, Clinical Trials, and More
The new year is off to an exciting start here at Pfizer!Already this year, we launched a new episode of “Rewrite the Recipe,” shined a light on the story of a lung cancer patient, The Pfizer Foundation has expanded its Action & Impact initiative, and that’s just the beginning.During a busy trip to Davos, CEO Albert Bourla shared Pfizer’s strategic priorities for the year, sat down with The Wall Street Journal to discuss how the healthcare landscape is changing, and joined industry experts for...
December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More
Happy New Year! Pay some final respects to 2025 with our monthly look back at Pfizer’s social channels.In the final month of the year, Pfizer shared an exciting innovation in cancer research, highlighted challenges faced by community-based organizations, and raised awareness for Alopecia Areata and sickle cell.Meanwhile, CEO Albert Bourla recognized the Pfizer team for our accomplishments in 2025 and shared his optimism for the upcoming year, highlighted our presence at major conferences, and...
The Power of Knowing: Medley’s Edith Cooper Talks Equity in AI
Over the summer, Pfizer launched “The Power of Knowing,” a video series hosted by our Chief Digital and Technology Officer, Lidia Fonseca. The series explores how artificial intelligence (AI) is unlocking innovation that was previously out of reach via interviews with industry leaders at the forefront of these changes. Today we’re excited to share a new installment that touches on a topic that’s so important to Pfizer that the concept serves as one of our core values: equity.Equity may not...
November Social Media Round-Up—Third-Quarter Earnings, Metsera Acquisition, and More
This past November, our plates weren’t the only things that were full. Pfizer’s social channels are bursting with updates—head over to our corporate channels for the latest news.Pfizer launched two new video series: “Rewrite the Recipe” and “Equity in AA Care,” celebrated The Pfizer Foundation winning a 2025 Citizens Award, and spotlighted caregivers for Lung Cancer Awareness month.CEO Albert Bourla announced the completion of Pfizer’s acquisition of Metsera, welcomed our new colleagues, and...
Accenture CEO Talks AI’s New Frontier on The Power of Knowing
Knowledge changes everything. In a world where science, technology, and AI are converging, knowing isn’t just about information—it’s about unlocking possibilities that redefine what’s achievable for humanity. For those of us at the intersection of health and technology, this knowledge becomes action: accelerating discovery, streamlining processes, and strengthening connections that bring hope and healing to millions.That’s why we launched “The Power of Knowing,” a video series hosted by our...
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Roughly one in three Americans is at risk for heart failure1, a condition where the heart can no longer effectively pump blood. And one in four will develop heart failure at some point in their lives1. Behind these statistics is a complex issue: the causes of heart failure differ widely among affected individuals. And identifying the underlying cause – especially if it’s rare – can be tricky.Among the less recognized causes is transthyretin amyloid cardiomyopathy, or ATTR-CM, which can mimic...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.